Site Search
Professionals 687 results
Capabilities 88 results
Industry
Insurance plays an essential role in risk mitigation for financial services companies. As risks evolve, questions often arise concerning the scope of insurance coverage and the interpretation and application of policy provisions. Winston’s insurance lawyers provide companies with best-in-class advice, corporate and transactional counsel, and, if need be, litigation defense in high-stakes coverage disputes and class actions. We have achieved excellent outcomes for our clients in matters involving a wide variety of insurance policies and claims, including cybersecurity, travel, long-term care, and annuities, among others. Moreover, we have experience in emerging issues and industries, such as blockchain technology and artificial intelligence, both of which present insurers with a unique and complicated set of risks and opportunities.
Industry
Winston offers a full-service energy practice. With four decades of experience handling a broad array of services for participants across the energy industry and in key markets worldwide, our practitioners have developed a deep familiarity and keen sense of the market. Our experience spans electric generation, transmission, distribution, and fuel supply and transportation in the power sector—including conventional and renewable resources—as well as the upstream, midstream, downstream, and oilfield services segments in the oil and gas sector. Additionally, our team is at the forefront of the flourishing market for energy transition, and we bring practical experience, perspective, and innovative thinking to this rapidly expanding segment of energy sector.
Industry
Experience 83 results
Experience
|March 30, 2026
Winston & Strawn LLP Paris advised NextStage AM on its investment in Evoluderm, a leading French player in the hygiene and beauty sector. This growth capital transaction, led by NextStage AM as a minority investor, will provide Nathalie and Gabriel Aiach – founders and majority shareholders with over 20 years’ expertise in the cosmetics sector – with the means to accelerate their ambition: to make Evoluderm an iconic brand, ranking among the world leaders in accessible, high-quality beauty. Founded in 2004, Evoluderm has established itself over the last five years as a benchmark in the health and beauty sector, distributed in over 100 countries. The brand has thus experienced remarkable growth, with turnover tripling over the last three years to reach nearly €40 million in 2025. With the support of NextStage AM, Evoluderm is embarking on an ambitious development plan to consolidate its position as a market leader.
Experience
|March 18, 2026
Winston & Strawn LLP Advises Maxim Group LLC on $100 Million IPO of BHAV Acquisition Corp
Winston & Strawn LLP represented the underwriter, Maxim Group LLC, in connection with the $100 million initial public offering of BHAV Acquisition Corp. The offering consisted of 10,000,000 units priced at $10.00 per unit, with each unit comprising one Class A ordinary share and one right. Each right entitles the holder to receive one-fourth (1/4) of one Class A ordinary share upon the consummation of the Company’s initial business combination.
Experience
|March 10, 2026
Winston Advising Dawn Foods in its Sale to Puratos
A Winston team led by Peter Clarke and John Secaras is representing Dawn Foods in connection with its definitive agreement to be acquired by Puratos.
Insights & News 2,853 results
Sponsorship
|7 May 2026
Winston Sponsors Sport Resolutions Conference 2026
Winston is pleased to sponsor the annual Sport Resolutions Conference, which will take place at the Leonardo Royal London St Paul’s Hotel.
Recognitions
|April 20, 2026
|Less Than 1 Min Read
Jason Campbell Named to Los Angeles Business Journal’s 2026 Top 100 Lawyers List
Winston partner Jason Campbell was named to the Los Angeles Business Journal’s 2026 Top 100 Lawyers list. This honor recognizes lawyers who not only set the standard for excellence in law but also demonstrate an outstanding commitment to advancing the legal profession and the greater Los Angeles community.
Press Release
|April 20, 2026
|1 Min Read
Winston Strengthens Texas Intellectual Property Practice with Aimee Fagan
Dallas, TX – April 20, 2026 – Winston & Strawn LLP announced today that Aimee Fagan has joined the firm as a partner in the Litigation Department and the Intellectual Property Practice in Dallas.Aimee is a first-chair trial lawyer whose practice focuses on intellectual property and complex commercial litigation. She represents clients in high-stakes disputes, with significant experience in technology and IP matters, particularly within the energy sector, as well as across the technology, financial services, private equity, medical, and retail industries.“I’m excited to join such a dynamic team that is highly regarded for both its substantial trial capabilities and its deep experience managing complex IP and commercial disputes,” Aimee said. “I look forward to leveraging my experience and collaborating across the Dallas and Houston offices to deliver the high-caliber client service for which Winston is known.”Aimee’s patent and trade secret litigation experience, particularly in the energy sector, further enhances the firm’s established strengths and platform in IP litigation across Texas.
Other Results 57 results
Site Content
The Illinois Biometric Invasion of Privacy Act (BIPA), enacted in 2008, grants Illinois consumers the right to their own biometric data, such as fingerprints, retina or iris information, voiceprints, and DNA. Under the BIPA, private companies are prohibited from collecting biometric information unless (1) the person consents in writing and (2) the companies inform the person in writing of what data is being collected, for what purpose, and for how long. Besides the notice and consent requirement, the law also bans any company from selling or otherwise profiting from consumers’ biometrics.
Site Content
The Illinois Genetic Information Privacy Act (GIPA), enacted in 1998, prohibits employers and their agents from conditioning employment on genetic data, or from using genetic data in discriminatory ways. The statute also prohibits insurers from seeking genetic information to use in connection with accident or health insurance policies.